Home > Insider Trading > Filing (0001707925-20-000057)

Filing Details

Accession Number:: 0001707925-20-000057
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-21 14:56:13
Reporting Period:: 2020-08-19

Accepted Time:: 2020-08-21 14:56:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1707925	Linde Plc	LIN	Industrial Inorganic Chemicals (2810)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1793274	Andreas Opfermann	C/O Linde Plc The Priestley Centre, 10 Priestley Road Guildford, Surrey X0 GU2 7XY	Executive Vp, Americas	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2020-08-19	457	$1.92	503	No	4	M	Direct
Ordinary Shares	Disposition	2020-08-19	5	$247.70	498	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (right to buy)	Disposition	2020-08-19	457	$0.00	457	$1.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-06-01	2021-06-01	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Restricted Stock Units	$0.00			2,145	2,145	Direct
Ordinary Shares	Restricted Stock Units	$0.00			93	93	Direct
Ordinary Shares	Restricted Stock Units	$0.00			320	320	Direct
Ordinary Shares	Stock Option (right to buy)	$173.13	2021-03-09	2030-03-09	26,090	26,090	Direct
Ordinary Shares	Stock Option (right to buy)	$1.92	2021-06-07	2022-06-07	387	387	Direct
Ordinary Shares	Stock Option (right to buy)	$176.63		2029-03-20	3,600	3,600	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	2,145	2,145	Direct
	93	93	Direct
	320	320	Direct
2030-03-09	26,090	26,090	Direct
2022-06-07	387	387	Direct
2029-03-20	3,600	3,600	Direct

Footnotes

Ordinary shares sold to pay exercise price, and the reporting person retained the 452 shares net of the sale of shares.
Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units ("RSUs") and stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The RSUs and stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these RSU and stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
Restricted Stock Units that will vest in full and payout on or about June 7, 2021 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shaes on a one-for-one basis.
This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
This option vests over three years in three consecutive equal annual installments beginning on March 20,2020.